Assignee
ABION INC
KR·20 granted patents·8 pending applications·3 citations·filing 2013–2023
Top patents by PatentIndex Score
28 records- 0180US11107552B2Data processing, analysis method of gene expression data to identify endogenous reference genesABION INC·Filed 2018·Granted Aug 31, 2021·1 cites·2 claims
- 0279US11464832B2Composition for treating or sensitizing interferon beta resistant cancer disease comprising cFLIP siRNAABION INC·Filed 2017·Granted Oct 11, 2022·1 cites·5 claims
- 0379US10304561B2Data processing, analysis method of gene expression data to identify endogenous reference genesABION INC·Filed 2017·Granted May 28, 2019·1 cites·2 claims
- 0478US12371437B2Method of preparing camsylate salts of triazolopyrazine derivativesABION INC·Filed 2023·Granted Jul 29, 2025·0 cites·5 claims
- 0576US12528817B2Method of inhibiting kinase by mesylate salts of triazolopyrazine derivativesABION INC·Filed 2023·Granted Jan 20, 2026·0 cites·6 claims
- 0673US12377132B2Method for treating or sensitizing interferon beta resistant cancer comprising cFLIP siRNAABION INC·Filed 2022·Granted Aug 5, 2025·0 cites·10 claims
- 0773US12275740B2Method of inhibiting kinase by camsylate salts of triazolopyrazine derivativesABION INC·Filed 2023·Granted Apr 15, 2025·0 cites·5 claims
- 0871US12084450B2Mesylate salts of triazolopyrazine derivativesABION INC·Filed 2022·Granted Sep 10, 2024·0 cites·17 claims
- 0967US11964979B2Camsylate salts of triazolopyrazine derivativesABION INC·Filed 2022·Granted Apr 23, 2024·0 cites·12 claims
- 1065US11111536B2Method for determining cross contamination of mouse genes for human cells in a patient-derived xenograft cellsABION INC·Filed 2019·Granted Sep 7, 2021·0 cites·4 claims
- 1163US11987582B2Maleate salts of triazolopyrazine derivatives, compositions, methods of use, and processes of manufacturing the sameABION INC·Filed 2021·Granted May 21, 2024·0 cites·38 claims
- 1260US2025271434A1Method for predicting prognosis of breast cancer patient using ctc expressing c-metABION INC·Filed 2023·Application pending·0 cites
- 1358US10576158B2Immune conjugate having dendron conjugated to antibody and use thereofABION INC·Filed 2017·Granted Mar 3, 2020·0 cites·11 claims
- 1457US10472678B2Reagent for detecting cross contamination of PDX-model related with human and mouse, the kit comprising the same, and the method for the cross contamination detectionABION INC·Filed 2017·Granted Nov 12, 2019·0 cites·6 claims
- 1557US2025281576A1Prophylactic administration method against respiratory virus, comprising administering interferon-beta to potential respiratory virus-infected subjectABION INC·Filed 2022·Application pending·0 cites
- 1653US9719093B2Composition for treating cancer associated with HPV infectionABION INC·Filed 2013·Granted Aug 1, 2017·0 cites·3 claims
- 1753US2018153932A1METHOD FOR MAINTAINING INCREASED INTRACELLULAR p53 LEVEL, INDUCED BY PLATINUM-BASED ANTICANCER DRUG, AND APPLICATION THEREOFABION INC·Filed 2017·Application pending·0 cites
- 1852US2023159605A1Human interferon-beta variant with double mutation and method for improving stability of human interferon-beta variantABION INC·Filed 2021·Application pending·0 cites
- 1951US12098198B2Antibody binding specifically to ECL-2 of claudin 3, fragment thereof, and use thereofABION INC·Filed 2019·Granted Sep 24, 2024·0 cites·17 claims
- 2051US10538529B2Polymorphic forms of triazolopyrazine derivatives and method of preparing the sameABION INC·Filed 2018·Granted Jan 21, 2020·0 cites·30 claims
- 2151US2022259260A1Method for purifying diglycosylated interferon-beta proteinABION INC·Filed 2020·Application pending·0 cites
- 2251US2024058273A1Method for preparing pharmaceutical formulation of tablet containing trizolopyrazine derivative as an active ingredientABION INC·Filed 2021·Application pending·0 cites
- 2350US12582707B2In-vitro transcript MRNA and pharmaceutical composition comprising sameABION INC·Filed 2021·Granted Mar 24, 2026·0 cites·10 claims
- 2446US2017198291A1Composition for treating cancer associated with hpv infectionABION INC·Filed 2017·Application pending·0 cites
- 2540US11207411B2Stabilized preparation of interferon beta variantABION INC·Filed 2017·Granted Dec 28, 2021·0 cites·6 claims
- 2639US11759500B2PEGylated interferon-beta variantABION INC·Filed 2015·Granted Sep 19, 2023·0 cites·12 claims
- 2736US11286296B2Anti-human ninjurin-1 (NINJ-1) antibodies and methods for detecting human NINJ-1ABION INC·Filed 2017·Granted Mar 29, 2022·0 cites·8 claims
- 2832US2018135055A1Composition for cancer cell sensitization containing as active ingredient substance inhibiting expression of oncogene of hpv virusABION INC·Filed 2018·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →